China Regenerative Medicine International Limited (HKG:8158)
Hong Kong · Delayed Price · Currency is HKD 0.2320
+0.0120 (5.45%)
Aug 4, 2026, 11:43 AM HKT
HKG:8158 Market Cap
HKG:8158 has a market cap or net worth of 66.94 million as of August 3, 2026. Its market cap has decreased by -75.28% in one year.
Market Cap
66.94M
Enterprise Value
110.07M
Revenue
72.06M
Ranking
n/a
PE Ratio
2.43
Stock Price
0.23
ChartMarket Cap Chart
Since July 18, 2001, HKG:8158's market cap has decreased from 67.20M to 66.94M, a decrease of -0.39%. That is a compound annual growth rate of -0.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 69.07M | -45.95% |
| Dec 31, 2025 | 127.79M | 42.37% |
| Dec 31, 2024 | 89.75M | -46.36% |
| Dec 29, 2023 | 167.34M | -47.18% |
| Dec 30, 2022 | 316.83M | -60.36% |
| Dec 31, 2021 | 799.20M | -50.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kintor Pharmaceutical | 807.38M |
| Wuhan YZY Biopharma | 715.30M |
| Brii Biosciences | 674.89M |
| JW (Cayman) Therapeutics Co. | 653.49M |
| Shanghai Bio-heart Biological Technology | 552.56M |
| 3D Medicines | 536.11M |
| Uni-Bio Science Group | 453.81M |
| Transcenta Holding | 435.18M |